Found: 12
Select item for more details and to access through your institution.
FIVE‐YEAR UPDATE OF THE FIRST‐LINE IMCL‐2015 GELTAMO STUDY. PROLONGED MOLECULAR AND CLINICAL RESPONSES WERE OBSERVED AFTER MRD‐DRIVEN IBRUTINIB DISCONTINUATION.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 148, doi. 10.1002/hon.3163_98
- By:
- Publication type:
- Article
TESTICULAR LARGE B‐CELL LYMPHOMA IS GENETICALLY SIMILAR TO PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA AND DISTINCT FROM NODAL DIFFUSE LARGE B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 244, doi. 10.1002/hon.3164_158
- By:
- Publication type:
- Article
A SIMPLE EPIGENETIC SIGNATURE DEFINES TWO BIOLOGIC GROUPS OF MANTLE CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.58_2879
- By:
- Publication type:
- Article
TESTICULAR DIFFUSE LARGE B‐CELL LYMPHOMA: CLINICO‐BIOLOGICAL CHARACTERIZATION, EVALUATION OF TREATMENT RESPONSE AND SURVIVAL.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.15_2880
- By:
- Publication type:
- Article
GENOTYPING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 346, doi. 10.1002/hon.9_2631
- By:
- Publication type:
- Article
PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.66_2631
- By:
- Publication type:
- Article
MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.1_2630
- By:
- Publication type:
- Article
GENOTYPING PRIMARY MEDIASTINAL B‐CELL LYMPHOMA (PMBCL) BY MEANS OF CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 346, doi. 10.1002/hon.9_2631
- By:
- Publication type:
- Article
PATTERNS OF CHANGE IN TREATMENT, SURVIVAL, HISTOLOGICAL TRANSFORMATION, AND SECONDARY MALIGNANCIES OF FOLLICULAR LYMPHOMA OVER THE LAST 4 DECADES: A SINGLE CENTER EXPERIENCE.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 395, doi. 10.1002/hon.66_2631
- By:
- Publication type:
- Article
MUTATIONAL LANDSCAPE OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT DIAGNOSIS AND AT PROGRESSION ASSESSED BY CIRCULATING TUMOR DNA ANALYSIS.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 186, doi. 10.1002/hon.1_2630
- By:
- Publication type:
- Article
INTEGRATIVE MUTATIONAL ANALYSIS OF PEDIATRIC-TYPE FOLLICULAR LYMPHOMA REVEALS TNFRSF14 AND MAP2K1 AS THE MOST FREQUENTLY MUTATED GENES.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 149, doi. 10.1002/hon.2438_1
- By:
- Publication type:
- Article
GENE MUTATIONS AND COPY NUMBER ALTERATIONS (CNA) PREDICT FOR EARLY FAILURE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH R-CHOP.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 93, doi. 10.1002/hon.2437_82
- By:
- Publication type:
- Article